Hepatitis C Virus (HCV) Infection Completed Phase 2 Trials for GS-9256 (DB12876)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01072695Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus InfectionTreatment